Floatz logo

(+)-VINCRISTINE

Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)

National Cancer Institute (NCI)Small moleculePhase 2Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 4A
Idarubicine
Technische Universität Dresden
Phase 4A
Mitoxantrone
Technische Universität Dresden
Phase 4BBB
METHOTREXATE
Technische Universität Dresden
Phase 3BBB
Cyclophosphamide
Sumithira Vasu
Phase 3BBB

View all 50 →

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →